- Home
- TR vs TARS Comparison
TR vs TARS Comparison
Compare TR & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- TARS
- Stock Information
- Founded
- TR 1896
- TARS 2016
- Country
- TR United States
- TARS United States
- Employees
- TR N/A
- TARS N/A
- Industry
- TR Specialty Foods
- TARS Medicinal Chemicals and Botanical Products
- Sector
- TR Consumer Staples
- TARS Health Care
- Exchange
- TR Nasdaq
- TARS Nasdaq
- Market Cap
- TR 2.2B
- TARS 2.0B
- IPO Year
- TR N/A
- TARS 2020
- Fundamental
- Price
- TR $32.34
- TARS $47.84
- Analyst Decision
- TR
- TARS Strong Buy
- Analyst Count
- TR 0
- TARS 6
- Target Price
- TR N/A
- TARS $56.00
- AVG Volume (30 Days)
- TR 100.8K
- TARS 449.4K
- Earning Date
- TR 03-03-2025
- TARS 02-25-2025
- Dividend Yield
- TR 0.56%
- TARS N/A
- EPS Growth
- TR 7.80
- TARS N/A
- EPS
- TR 1.31
- TARS N/A
- Revenue
- TR $727,121,000.00
- TARS $129,621,000.00
- Revenue This Year
- TR N/A
- TARS $921.89
- Revenue Next Year
- TR N/A
- TARS $85.83
- P/E Ratio
- TR $23.87
- TARS N/A
- Revenue Growth
- TR N/A
- TARS 801.96
- 52 Week Low
- TR $27.58
- TARS $20.08
- 52 Week High
- TR $34.00
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- TR 61.36
- TARS 39.21
- Support Level
- TR $30.92
- TARS $49.86
- Resistance Level
- TR $31.82
- TARS $53.22
- Average True Range (ATR)
- TR 0.85
- TARS 2.44
- MACD
- TR 0.14
- TARS -0.56
- Stochastic Oscillator
- TR 93.82
- TARS 7.09
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.